Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RBC antibody persistence.

H Schonewille1, H L Haak, A M van Zijl

  • 1Department of Hematology, Leyenburg Hospital, The Hague, The Netherlands. HEMATLEY@WORLDONLINE.NL

Transfusion
|September 16, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red-blood-cell alloimmunization and number of red-blood-cell transfusions.

Vox sanguinis·2011
Same author

Maternal red blood cell alloimmunisation in south western Uganda.

Transfusion medicine (Oxford, England)·2011
Same author

Assessment of the clinical transfusion practice at a regional referral hospital in Uganda.

Transfusion medicine (Oxford, England)·2010
Same author

Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.

Vox sanguinis·2009
Same author

Prevalence of HLA antibodies in transfused patients with and without red blood cell antibodies.

Transfusion·2007
Same author

[The anamnesis in antiquity; medical questions by Rufus Ephesius (1st to 2nd century AD)].

Nederlands tijdschrift voor geneeskunde·2007
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
See all related articles

Approximately 25% of red blood cell (RBC) alloantibodies became undetectable over time. Antibody persistence was influenced by the screening technique, not specificity, highlighting the importance of accurate antibody documentation.

Area of Science:

  • Immunology
  • Transfusion Medicine
  • Hematology

Background:

  • Exposure to foreign blood group antigens can trigger antibody production.
  • Antibody persistence varies significantly among individuals and antibody types.
  • Understanding RBC alloantibody persistence is crucial for transfusion safety.

Purpose of the Study:

  • To investigate the long-term persistence of clinically significant red blood cell (RBC) alloantibodies.
  • To analyze factors influencing the detectability of RBC alloantibodies over a 20-year period.

Main Methods:

  • Retrospective analysis of RBC antibody records from 1978-1997.
  • Inclusion of antibodies against Rh, K, Fy, Jk, and MNs blood group systems.
  • Defined antibody undetectability based on negative screening or panel studies.

Related Experiment Videos

Main Results:

  • 153 out of 593 (26%) antibodies became undetectable over time.
  • Antibody persistence was not influenced by patient age, sex, or antibody specificity.
  • More sensitive screening techniques correlated with decreased antibody persistence (p=0.0002).

Conclusions:

  • A significant proportion of RBC alloantibodies can become undetectable.
  • The method of antibody detection, not specificity, impacts persistence.
  • Accurate antibody documentation is vital for preventing delayed hemolytic transfusion reactions.